Merchavia Holdings and Investments Ltd. logo

Merchavia Holdings and Investments Ltd. (MRHL)

Market Closed
10 Aug, 15:25
TASE TASE
178. 20
ILA
+5.8
+3.3643%
ILA
3.4B Market Cap
11.74 P/E Ratio
- Div Yield
8,102 Volume
0 Eps
172.4 ILA
Previous Close
Add Transaction
Day Range
172.4 181.8
Year Range
0.82 329.8
Want to track MRHL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

MRHL closed today higher at 178.2 ILA, an increase of 3.3643% from yesterday's close, completing a monthly increase of 11.4447% or 18.3 ILA. Over the past 12 months, MRHL stock lost -19.6211%.
MRHL is not paying dividends to its shareholders.
The last earnings report, released on Sep 06, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Merchavia Holdings and Investments Ltd. has completed 2 stock splits, with the recent split occurring on Jan 14, 2024.
The company's stock is traded on one exchange.

MRHL Chart

People also search for

Meitav Investments House Ltd.
13,810 ILA
-1.7082%
Autonomous Guard Ltd
900.7 ILA
-1.6596%
PAZ
Paz Retail and Energy Ltd.
84,870 ILA
-0.9223%
Orion Retail Properties Ltd
190.8 ILA
-1.4972%
Spring Ventures Ltd.
480 ILA
-4.4966%

Merchavia Holdings and Investments Ltd. (MRHL) FAQ

What is the stock price today?

The current price is 178.20 ILA.

On which exchange is it traded?

Merchavia Holdings and Investments Ltd. is listed on TASE.

What is its stock symbol?

The ticker symbol is MRHL.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 3.4B.

Has Merchavia Holdings and Investments Ltd. ever had a stock split?

Merchavia Holdings and Investments Ltd. had 2 splits and the recent split was on Jan 14, 2024.

Merchavia Holdings and Investments Ltd. Profile

Financial Services Industry
Financials Sector
Mr. Eli Arad CEO
TASE Exchange
IL0002570146 ISIN
Israel Country
1 Employees
- Last Dividend
14 Jan 2024 Last Split
- IPO Date

Overview

Merchavia Holdings and Investments Ltd., originally established in 1972 and formerly known as Nepco Star Ltd. until November 2014, is an investment firm based in Bnei Brak, Israel, with a focus on med tech ventures. The company specializes in the investment and development of advanced medical technologies and products, particularly those aimed at diagnostics, monitoring, and treatment in various fields within the healthcare industry. Merchavia's portfolio spans innovative solutions across cancer detection, wearable sensor technology, air quality management, pain management, blood testing, cannabis inhalation devices, neuromonitoring tools, and women's health products, demonstrating a broad spectrum of interests within the med tech sector.

Products and Services

  • Diagnostic Technology for Cancer Detection: This development focuses on innovative diagnostic tools designed for the early detection of cancer, employing cutting-edge technologies to improve accuracy and patient outcomes.

  • Wearable Equipment: Merchavia invests in the development of wearable medical devices, such as watches, bracelets, and patches, enhanced with sensor technology for medical diagnosis and monitoring, facilitating remote patient monitoring and data collection.

  • Aura Smart Air: A data-driven air quality management platform that utilizes smart sensors and user behavior algorithms to monitor air quality both indoors and outdoors, offering real-time insights for healthier living environments.

  • TrainPain: A digital solution aiming to improve the mental and emotional well-being of individuals suffering from neuropathic and fibromyalgia pain, supporting pain management through technology.

  • RevDx (Revolutionary Diagnostics): This handheld device allows for on-the-spot complete blood count tests, facilitating immediate diagnostics and healthcare decision-making outside traditional laboratory settings.

  • Electrical Cannabis Inhaler Device: A rechargeable inhaler device with Bluetooth connectivity to the VEOLI App, which manages dosing and tracks capsules supply, offering a modern approach to medicinal cannabis consumption.

  • AI-Driven Neuromonitoring Tool: An artificial intelligence-driven tool used in operating rooms to prevent nerve injury during surgical procedures, enhancing patient safety and surgical outcomes.

  • Women's Health Products: Merchavia is engaged in the development and commercialization of innovative products for women's health, including Ballerine, a hormone-free intrauterine contraceptive, and a Phase IIa clinical study on a spherical endometrial ablation device for abnormal uterine bleeding treatment.

Contact Information

Address: BSR Tower No. 4
Phone: 972 3 578 8770